Form 8-K - Current report:
SEC Accession No. 0001193125-25-004129
Filing Date
2025-01-10
Accepted
2025-01-10 08:08:38
Documents
13
Period of Report
2025-01-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d851032d8k.htm   iXBRL 8-K 36360
  Complete submission text file 0001193125-25-004129.txt   165993

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA clym-20250108.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE clym-20250108_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clym-20250108_pre.xml EX-101.PRE 11701
15 EXTRACTED XBRL INSTANCE DOCUMENT d851032d8k_htm.xml XML 3771
Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 25520530
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)